Efficacy and safety in unresectable hepatocellular carcinoma with VP4 tumor embolus using sinilimab plus bevacizumab: A retrospective analysis of real-world evidence

被引：0
|
作者：
Cheng, Jiamin
Chen, Bowen
Zhang, Xinfeng
Su, Guodong
Peng, Caiyun
Lei, Jin
Yu, Lingxiang
Li, Yinyin
Lu, Yinying
机构：
[1] Peoples Liberat Army Gen Hosp, Senior Dept Hepatol, Med Ctr 5, Beijing, Peoples R China
[2] Peking Univ, Clin Med Sch 302, Beijing, Peoples R China
[3] Anhui Med Univ, Sch Clin Med 5, Hefei, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16156
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety in unresectable hepatocellular carcinoma using atezolizumab plus bevacizumab in later-line: A retrospective analysis of real-world evidence.
    Cheng, Jiamin
    Chen, Bowen
    Zhang, Xinfeng
    Su, Guodong
    Peng, Caiyun
    Zhou, Lin
    Lei, Jin
    Li, Yinyin
    Lu, Yinying
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] Efficacy and safety in advanced hepatocellular carcinoma using atezolizumab plus bevacizumab combined with interventional therapy: A retrospective analysis of real-world evidence.
    Cheng, Jiamin
    Chen, Bowen
    Jing, Yi
    Lu, Yinying
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16112 - E16112
  • [3] Effectiveness and safety of atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma: A multicenter, retrospective real-world study in China
    Zhang, Hui
    Shao, Minghua
    Tan, Binbin
    Fu, Yin
    Yuan
    Chen, Hailei
    CANCER RESEARCH, 2024, 84 (06)
  • [4] Early Tumor Response and Safety of Atezolizumab Plus Bevacizumab for Patients with Unresectable Hepatocellular Carcinoma in Real-World Practice
    Ando, Yuwa
    Kawaoka, Tomokazu
    Kosaka, Masanari
    Shirane, Yuki
    Johira, Yusuke
    Miura, Ryoichi
    Murakami, Serami
    Yano, Shigeki
    Amioka, Kei
    Naruto, Kensuke
    Kosaka, Yumi
    Uchikawa, Shinsuke
    Kodama, Kenichiro
    Fujino, Hatsue
    Nakahara, Takashi
    Ono, Atsushi
    Murakami, Eisuke
    Yamauchi, Masami
    Okamoto, Wataru
    Takahashi, Shoichi
    Imamura, Michio
    Chayama, Kazuaki
    Aikata, Hiroshi
    CANCERS, 2021, 13 (16)
  • [5] Initial Experience With Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma: A Real-world Retrospective Study
    Takeda, Soichi
    Namisaki, Tadashi
    Tsuji, Yuki
    Fujimoto, Yuki
    Murata, Koji
    Enomoto, Masahide
    Fujinaga, Yukihisa
    Nishimura, Norihisa
    Kitagawa, Koh
    Takaya, Hiroaki
    Kaji, Kosuke
    Inoue, Takashi
    Kawaratani, Hideto
    Akahane, Takemi
    Mitoro, Akira
    Yoshiji, Hitoshi
    ANTICANCER RESEARCH, 2022, 42 (11) : 5465 - 5473
  • [6] Efficacy of Atezolizumab Plus Bevacizumab Combined with Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Real-World Study
    Shen, Xiao
    Zhang, Jin-Xing
    Liu, Jin
    Liu, Sheng
    Shi, Hai-Bin
    Cheng, Yuan
    Zhang, Qing-Qiao
    Yin, Guo-Wen
    Zu, Qing-Quan
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2024, 11 : 1993 - 2003
  • [7] EARLY TUMOR RESPONSE AND SAFETY OF ATEZOLIZUMAB PLUS BEVACIZUMAB FOR PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA IN REAL WORLD PRACTICE
    Ando, Yuwa
    Kawaoka, Tomokazu
    Amioka, Kei
    Uchikawa, Shinsuke
    Kodama, Kenichiro
    Fujino, Hatsue
    Nakahara, Takashi
    Ono, Atsushi
    Murakami, Eisuke
    Yamauchi, Masami
    Imamura, Michio
    Aikata, Hiroshi
    HEPATOLOGY, 2021, 74 : 636A - 637A
  • [8] THE EFFICACY AND SAFETY OF ATEZOLIZUMAB & BEVACIZUMAB IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA: THE REAL WORLD DATA
    Yoo, Sung Hwan
    Lee, Hyun Woong
    Lee, Jung Il
    HEPATOLOGY, 2023, 78 : S1898 - S1899
  • [9] Efficacy, safety, and biomarker analysis of TACE combined with lenvatinib plus sintilimab in unresectable hepatocellular carcinoma: a real-world study
    Meng, Lingzhan
    Li, Hu
    Ji, Yingjie
    Yu, Peng
    Wang, Zizheng
    Cao, Li
    Shi, Bin
    Shao, Yanling
    Yan, Jin
    Gao, Yinjie
    Zhu, Zhenyu
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 74 (01)
  • [10] INITIAL EXPERIENCE OF ATEZOLIZUMAB PLUS BEVACIZUMAB FOR UNRESECTABLE HEPATOCELLULAR CARCINOMA IN REAL-WORLD CLINICAL PRACTICE
    Iwamoto, Hideki
    Shimose, Shigeo
    Takashi, Niizeki
    Noda, Yu
    Shirono, Tomotake
    Nakano, Masahito
    Okamura, Shusuke
    Kamachi, Naoki
    Suzuki, Hiroyuki
    Kuromatsu, Ryoko
    Koga, Hironori
    Torimura, Takuji
    HEPATOLOGY, 2021, 74 : 652A - 652A
12345